Table 1.

Summary of TTV prevalence in different study groups

Study group	No. of samples (N)	TTV positive(%age)	TTV negative (%age)
HBV Patients	116	104(89.7%)	12(10.3%)
HCV Patients	100	90(90.0%)	10(10.0%)
Control Population	40	37(92.5%)	3(7.5%)